The results send a ‘clear, pragmatic message’ of IL-17 inhibition’s greater potency over IL-12/23 inhibition, an expert says.

CHICAGO -- Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in ...

Patients with psoriatic arthritis who received GLP-1 receptor agonists exhibited lower risks for mortality and cardiovascular ...

Although findings from a large retrospective study supports these positive effects of taking a GLP-1, it’s unclear whether ...

Some people with psoriatic arthritis (PsA) may have a disease that is difficult to manage (D2M) or does not respond to ...

Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.

Psoriatic arthritis disease activity levels appear to increase on average during perimenopause before decreasing slightly ...

What are called autoimmune diseases can affect just about every part of the body – and tens of millions of people. While most ...

GLP-1RAs were associated with lower risks for major adverse cardiac events, including heart failure, among patients with ...

Following a transformational investment from the Krembil Foundation, York has officially launched the Psoriatic Arthritis Collaborative and Applied Research Excellence (PsA CARE) Hub, the first ...

Following the NDA submission for icotrokinra treatment of adults and adolescents with moderate to severe plaque psoriasis to ...

Perimenopause was linked to higher PsA disease activity and greater tender/swollen joint counts when compared with the pre- ...